{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:06:57Z","timestamp":1789391217409,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.addbeh.2012.12.018","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T15:05:25Z","timestamp":1357311925000},"page":"2044-2051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil"],"prefix":"10.1016","volume":"38","author":[{"given":"Jo\u00e3o Maria","family":"Corr\u00eaa Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Antonio","family":"Baltieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2012.12.018_bb0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2008.08.004","article-title":"Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial","volume":"107","author":"Akhondzadeh","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview","volume":"22","author":"Amorim","year":"2000","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3109\/10826089609063990","article-title":"Drinking-related assessment instruments: cross-cultural studies","volume":"31","author":"Annis","year":"1996","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","article-title":"The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior","volume":"19","author":"Anton","year":"1995","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000336530","article-title":"The role of two clusters of male alcoholics in treatment retention","volume":"18","author":"Baltieri","year":"2012","journal-title":"European Addiction Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0030","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1360-0443.2008.02355.x","article-title":"Comparing topiramate with naltrexone in the treatment of alcohol dependence","volume":"103","author":"Baltieri","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2009.05.025","article-title":"Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients","volume":"105","author":"Baltieri","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1345\/aph.1P008","article-title":"The role of ondansetron in the treatment of schizophrenia","volume":"44","author":"Bennett","year":"2010","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"Journal of Studies on Alcohol"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0050","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1590\/S1516-44462004000500011","article-title":"The pharmacologic treatment of the alcohol dependence","volume":"26","author":"Castro","year":"2004","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/FPC.0b013e328322e73d","article-title":"From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics","volume":"19","author":"Chu","year":"2009","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/106002809502901016","article-title":"Ondansetron use for smoking cessation","volume":"29","author":"Cropp","year":"1995","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0741-8329(95)00023-K","article-title":"Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats","volume":"12","author":"Dyr","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0376-8716(98)00180-X","article-title":"Alcohol abusers who want to quit smoking: implications for clinical treatment","volume":"54","author":"Ellingstad","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00520-008-0438-9","article-title":"Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study","volume":"16","author":"Fabi","year":"2008","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jad.2005.12.047","article-title":"Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms","volume":"92","author":"Faris","year":"2006","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behavior Research Methods"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0090","first-page":"280","article-title":"Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease","volume":"21","author":"Friedberg","year":"1998","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0100","series-title":"Markov Chain Monte Carlo in Practice \u2014 Interdisciplinary Statistics","author":"Gilks","year":"1996"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10550490902925540","article-title":"Engagement and retention in outpatient alcoholism treatment for women","volume":"18","author":"Graff","year":"2009","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4067\/S0716-97602004000200004","article-title":"Intake of beer, wine and spirits and risk of heavy drinking and alcoholic cirrhosis","volume":"37","author":"Gronbaek","year":"2004","journal-title":"Biological Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00213-006-0337-z","article-title":"5HT(3) antagonism abolishes the emotion potentiated startle effect in humans","volume":"186","author":"Harmer","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/1082-989X.2.1.64","article-title":"Application of random-effects pattern-mixture models for missing data in longitudinal studies","volume":"2","author":"Hedeker","year":"1997","journal-title":"Psychological Methods"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1198\/000313001317098266","article-title":"Multiple imputation in practice: comparison of software packages for regression models with missing values","volume":"55","author":"Horton","year":"2001","journal-title":"The American Statistician"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2010.10050755","article-title":"Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking","volume":"168","author":"Johnson","year":"2011","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-002-1002-9","article-title":"Ondansetron reduces the craving of biologically predisposed alcoholics","volume":"160","author":"Johnson","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0145","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0150","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15288\/jsa.2004.65.681","article-title":"A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment","volume":"65","author":"Joseph","year":"2004","journal-title":"Journal of Studies on Alcohol"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1530-0277.2008.00835.x","article-title":"A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline","volume":"33","author":"Kenna","year":"2009","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1360-0443.2000.9533394.x","article-title":"Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries","volume":"95","author":"Kerr","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1530-0277.1996.tb01036.x","article-title":"Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers","volume":"20","author":"Kranzler","year":"1996","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0175","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yrtph.2007.12.008","article-title":"Defining maximum levels of higher alcohols in alcoholic beverages and surrogate alcohol products","volume":"50","author":"Lachenmeier","year":"2008","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0190","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1007\/s00406-010-0153-7","article-title":"Individualized treatment in alcohol-dependent patients","volume":"260","author":"Mann","year":"2010","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.ALC.0000113419.99915.DA","article-title":"Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism","volume":"28","author":"McBride","year":"2004","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.6004\/jnccn.2007.0005","article-title":"Are all 5-HT3 receptor antagonists the same?","volume":"5","author":"McNulty","year":"2007","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/JMN:27:2:219","article-title":"Allelic association analysis of the functional insertion\/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder","volume":"27","author":"Meira-Lima","year":"2005","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<225::AID-AJMG4>3.0.CO;2-V","article-title":"Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia","volume":"81","author":"Mendes de Oliveira","year":"1998","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","article-title":"Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people","volume":"65","author":"Myrick","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00019442-200211000-00013","article-title":"Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes","volume":"10","author":"Oslin","year":"2002","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","article-title":"Color and genomic ancestry in Brazilians","volume":"100","author":"Parra","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0230","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.2004.055251","article-title":"Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study","volume":"54","author":"Piche","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1983.tb02484.x","article-title":"Development of a questionnaire to measure alcohol dependence","volume":"78","author":"Raistrick","year":"1983","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0240","first-page":"CD004332","article-title":"Acamprosate for alcohol dependence","volume":"8","author":"Rosner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10903127.2010.519822","article-title":"Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics","volume":"15","author":"Salvucci","year":"2011","journal-title":"Prehospital Emergency Care"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/alcalc\/agm027","article-title":"Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers","volume":"42","author":"Schmidt","year":"2007","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.166.4.511","article-title":"Ondansetron and opiate craving. A novel pharmacological approach to addiction","volume":"166","author":"Sell","year":"1995","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0260","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1530-0277.1994.tb00054.x","article-title":"Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence","volume":"18","author":"Sellers","year":"1994","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1176\/appi.ajp.157.2.287","article-title":"Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia","volume":"157","author":"Sirota","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The Drug Abuse Screening Test","volume":"7","author":"Skinner","year":"1982","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/hup.1145","article-title":"A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder","volume":"25","author":"Soltani","year":"2010","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0280","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0285","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0006-3223(95)00432-7","article-title":"Ondansetron alters human alcohol intoxication","volume":"40","author":"Swift","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.addbeh.2012.12.018_bb9000","series-title":"Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2001.tb00195.x","article-title":"Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders","volume":"7","author":"Ye","year":"2001","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.addbeh.2012.12.018_bb0295","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030646031200408X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030646031200408X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T19:54:59Z","timestamp":1562529299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030646031200408X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S030646031200408X"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2012.12.018","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2012.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}